SCHEMBL6535002

SCHEMBL6535002

CN(c1ccccc1)S(=O)(=O)c1ccccc1Cl

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCOLN3 Q8TDD5 1/20 0.78
PGR P06401 3/20 0.74
KDM4E B2RXH2 2/20 0.71
CA12 O43570 1/20 0.51
CA9 Q16790 1/20 0.51
HSD11B1 P28845 1/20 0.50
ALDH1A1 P00352 1/20 0.50
LMNA P02545 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.49
NR1H2 P55055 1/20 0.48
NR1H3 Q13133 1/20 0.48
HTR2A P28223 1/20 0.48
HTR2C P28335 1/20 0.48
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2D6 P10635 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2229460 0.80 PGR (0.54) MCOLN3PGRKDM4EHSD11B1ALDH1A1
SCHEMBL3853249 0.80 MCOLN3 (0.57) MCOLN3PGRKDM4ECA12CA9
SCHEMBL3822613 0.79 MCOLN3 (0.60) MCOLN3PGRKDM4ECA12CA9
SCHEMBL3823916 0.79 MCOLN3 (0.60) MCOLN3PGRKDM4ECA12CA9
SCHEMBL11232067 0.78 KDM4E (0.61) MCOLN3PGRKDM4ECA12CA9
SCHEMBL12577226 0.78 HSD11B1 (0.75) PGRHSD11B1NR1H2NR1H3
SCHEMBL16121117 0.78 NR1H3 (0.68) PGRHSD11B1NR1H2NR1H3
SCHEMBL4598847 0.78 HSD11B1 (0.75) PGRHSD11B1NR1H2NR1H3
SCHEMBL6534930 0.78 MCOLN3 (0.58) MCOLN3PGRKDM4ECA12CA9
SCHEMBL9355856 0.78 MCOLN3 (0.58) MCOLN3PGRKDM4ECA12CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1011652-A4 NOVEL DIARYLSULFONE NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS UNIV THE SCIENCES IN PHILADELP (US) 2004-12-22 EP disclosed
US-6303630-B1 TREATING HUMAN IMMUNODEFICIENCY VIRUS INFECTION BYADMINISTERING TO A HUMAN DIARYLSULFONE COMPOUND UNIVERSITY OF THE SCIENCES IN PHILADELPHIA 2001-10-16 US disclosed
EP-1011652-A1 NOVEL DIARYLSULFONE NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS University of the Sciences in Philadelphia (US) 2000-06-28 EP disclosed
US-6063790-A TREATMENT OF AIDS UNIVERSITY OF THE SCIENCES IN PHILADELPHIA (US) 2000-05-16 US disclosed
WO-1999006037-A1 NOVEL DIARYLSULFONE NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS UNIVERSITY OF THE SCIENCES IN PHILADELPHIA (US) 1999-02-11 WO disclosed